Kasinath B S, Block J A, Singh A K, Terhune W C, Maldonado R, Davalath S, Kallgren M J, Wanna L
Department of Medicine, University of Texas Health Science Center, San Antonio 78284.
Arch Biochem Biophys. 1994 Feb 15;309(1):149-59. doi: 10.1006/abbi.1994.1097.
In diabetic nephropathy the heparan sulfate proteoglycan (HSPG) content of the glomerular basement membrane (GBM) is reduced but the cellular mechanisms involved have not been studied. Glomerular epithelial cells (GEC) are thought to be the source of HSPG present in the GBM. In this study we examined if proteoglycan metabolism of the rat GEC in culture is dysregulated in a metabolic environment simulating diabetes. Following incubation for 8 days with a serum-supplemented medium containing 30 mM glucose and no added insulin, a significant increase in the overall synthesis of 35SO4-labeled molecules by the GEC was seen compared to control monolayers incubated with medium containing 5 mM glucose and insulin. Ion exchange chromatography revealed that 30 mM glucose did not alter the anionic charge density of proteoglycans, but significantly increased the amount of 35S-labeled low-anionic macromolecules in the medium; mannitol induced similar changes. Sepharose CL-4B chromatography, glycosaminoglycan analysis and immunoprecipitation of control cell layer proteoglycans demonstrated the presence of HSPG of hydrodynamic size, Kav 0.4, resembling rat GBM HSPG in size and antigenic nature. Incubation of GEC with 30 mM glucose resulted in a significant reduction (58%) in this HSPG species, an effect not seen with equimolar mannitol. Additionally, 30 mM glucose induced a significant increment in synthesis of a small HS species (Kav 0.71 on Sepharose CL-4B column) present in the cell layer. Our findings suggest that both osmotic and nonosmotic mechanisms are operative in dysregulation of glycopeptide metabolism by high-glucose medium and that reduced synthesis by the GEC may contribute to decreased content of GBM HSPG in diabetic nephropathy.
在糖尿病肾病中,肾小球基底膜(GBM)的硫酸乙酰肝素蛋白聚糖(HSPG)含量降低,但相关的细胞机制尚未得到研究。肾小球上皮细胞(GEC)被认为是GBM中HSPG的来源。在本研究中,我们检测了在模拟糖尿病的代谢环境中,培养的大鼠GEC的蛋白聚糖代谢是否失调。在用含30 mM葡萄糖且未添加胰岛素的血清补充培养基孵育8天后,与用含5 mM葡萄糖和胰岛素的培养基孵育的对照单层细胞相比,GEC合成的35SO4标记分子的总量显著增加。离子交换色谱显示,30 mM葡萄糖不会改变蛋白聚糖的阴离子电荷密度,但会显著增加培养基中35S标记的低阴离子大分子的量;甘露醇诱导了类似的变化。琼脂糖CL-4B色谱、糖胺聚糖分析以及对照细胞层蛋白聚糖的免疫沉淀表明,存在流体力学大小为Kav 0.4的HSPG,其大小和抗原性质与大鼠GBM HSPG相似。用30 mM葡萄糖孵育GEC会导致该HSPG种类显著减少(58%),等摩尔甘露醇处理则未观察到这种效应。此外,30 mM葡萄糖会诱导细胞层中存在的一种小的HS种类(在琼脂糖CL-4B柱上的Kav为0.71)的合成显著增加。我们的研究结果表明,渗透和非渗透机制在高糖培养基对糖肽代谢的失调中均起作用,并且GEC合成减少可能导致糖尿病肾病中GBM HSPG含量降低。